• Home page
• Themes guidance
• Information services
• Consultancy services
• Publications
• What's new
• About the HRC
• Contact the HRC

Medicines Transparency Alliance

Promoting transparency and accountability in the procurement and distribution of medicines

Consumers and civil society, 13 March meeting

Presentations

• Towards a medicines transparency alliance (MeTA)
• Utilizing electronic data (GPRM) to monitor & improve ARV medicine prices: a case for picking the low hanging fruit, Brenda Waning
• Ethical infrastructure for good governance in public pharmaceutical sector
• Good governance: role of civil society
• Perspectives on medicines transparency issues from an experienced, collaborative African health NGO
• Medicines transparency and the consumer: key issues, challenges, and promising directions
• Increasing transparency: lessons from the extractive industries

Related resources

• Ethical infrastructure for good governance in the public pharmaceutical sector

Consumer demand for medicines, 14 March meeting

Presentations

• Prices, access, and affordability: scoping household out of pocket payments for medicines
• Anthropological perspectives on medicines access and use
• Forecasting demand for critical medical technologies: issues & options
• Attitudes, behaviours and choices of consumers of medicines: perspectives from Ghana

Related resources

• ESRC-DFID research grant: Tracing pharmaceuticals in South Asia: regulation, distribution, and consumption